Stem Cells Translational Medicine (May 2021)

High‐throughput screening in postimplantation haploid epiblast stem cells reveals Hs3st3b1 as a modulator for reprogramming

  • Qian Gao,
  • Wenhao Zhang,
  • Yiding Zhao,
  • Yaru Tian,
  • Yuna Wang,
  • Jinxin Zhang,
  • Mengyang Geng,
  • Mei Xu,
  • Chunmeng Yao,
  • Haoyu Wang,
  • Luyuan Li,
  • Yan Liu,
  • Ling Shuai

DOI
https://doi.org/10.1002/sctm.20-0468
Journal volume & issue
Vol. 10, no. 5
pp. 743 – 755

Abstract

Read online

Abstract Epiblast stem cells (EpiSCs) derived from postimplantation epiblast are pluripotent stem cells, epigenetically distinct from embryonic stem cells (ESCs), which are widely used in reprogramming studies. Recent achieved haploid cell lines in mammalian species open a new era for high‐throughput genetic screening, due to their homozygous phenotypes. Here, we report the generation of mouse haploid EpiSCs (haEpiSCs) from postimplantation chimeric embryos at embryonic day 6.5 (E6.5). These cells maintain one set of chromosomes, express EpiSC‐specific genes, and have potentials to differentiate into three germ layers. We also develop a massive mutagenesis protocol with haEpiSCs, and subsequently perform reprogramming selection using this genome‐wide mutation library. Multiple modules related to various pathways are implicated. The validation experiments prove that knockout of Hst3st3b1 (one of the candidates) can promote reprogramming of EpiSCs to the ground state efficiently. Our results open the feasibility of utilizing haEpiSCs to elucidate fundamental biological processes including cell fate alternations.

Keywords